| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12602-011-9087-2 |
| P698 | PubMed publication ID | 26781733 |
| P2093 | author name string | Sagar R Jadhav | |
| Umesh Kr Shandilya | |||
| Vinod K Kansal | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial | Q24685494 | ||
| Microbial influences in inflammatory bowel diseases | Q29614264 | ||
| Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. | Q33610644 | ||
| Role of cytokines in the pathogenesis of inflammatory bowel disease | Q33896046 | ||
| Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis | Q34101968 | ||
| Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis | Q34381733 | ||
| Intestinal bacteria and ulcerative colitis | Q35105588 | ||
| Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics | Q35787456 | ||
| Probiotics and the management of inflammatory bowel disease. | Q35854517 | ||
| Review article: antibiotics and probiotics in inflammatory bowel disease | Q35880404 | ||
| Probiotics in the treatment of inflammatory bowel disease. | Q36457614 | ||
| Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. | Q36793930 | ||
| Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats | Q39677660 | ||
| Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis | Q39909705 | ||
| Aetiology and pathogenesis of chronic inflammatory bowel disease | Q40656846 | ||
| Probiotic bacteria enhance murine and human intestinal epithelial barrier function | Q40783633 | ||
| Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker | Q41552495 | ||
| Variable response to probiotics in two models of experimental colitis in rats. | Q44231461 | ||
| Infliximab for hospitalized patients with severe ulcerative colitis | Q44361904 | ||
| Pancreatic changes in TNBS-induced colitis in mice. | Q44664376 | ||
| VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss | Q47269710 | ||
| Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum alleviates age-inflicted oxidative stress and improves expression of biomarkers of ageing in mice. | Q50534464 | ||
| Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. | Q54450083 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice | Q59120727 | ||
| Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease | Q60711896 | ||
| Colorectal cancer risk and mortality in patients with ulcerative colitis | Q67522936 | ||
| Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? | Q77375025 | ||
| Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice | Q79840083 | ||
| Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis | Q80463944 | ||
| Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice | Q81014180 | ||
| Probiotics and inflammatory bowel diseases | Q83929578 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lactobacillus acidophilus | Q132644 |
| probiotics | Q1816730 | ||
| Bifidobacterium bifidum | Q2902072 | ||
| P304 | page(s) | 21-26 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Probiotics and antimicrobial proteins | Q27722862 |
| P1476 | title | Immunoprotective Effect of Probiotic Dahi Containing Lactobacillus acidophilus and Bifidobacterium bifidum on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice | |
| P478 | volume | 4 |
Search more.